Long-Acting Reversible Contraception: New Research to Reduce Unintended Pregnancy.
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Etonogestrel (Primary) ; Levonorgestrel (Primary) ; Copper; Ethinylestradiol/levonorgestrel; Medroxyprogesterone
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms LARC
- 01 Feb 2017 Status changed from active, no longer recruiting to completed.
- 18 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016.
- 16 May 2016 Planned End Date changed from 1 Jun 2015 to 1 Sep 2016.